News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Bioxel Pharma: Results For The Second Quarter Of 2006
August 22, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Bioxel Pharma Inc. (TSX VENTURE: BIP), a leading manufacturer of taxane active pharmaceutical ingredients and developer of targeted oncology drugs, today announced its results for the second quarter ended June 30, 2006.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Deals
Lilly, AI biotech Profluent ink $2.25B pact in search of genetic medicine ‘holy grail’
April 28, 2026
·
2 min read
·
Gabrielle Masson
Earnings
Novartis’ sales dip as generics pressure intensifies, radioequivalents loom
April 28, 2026
·
2 min read
·
Tristan Manalac
Venture capital
Big Pharma–backed Coultreon bags $125M series A to unlock alternative immune pathway
April 28, 2026
·
2 min read
·
Tristan Manalac
Deals
Sun Pharma beams up Organon in $11.75B acquisition
April 27, 2026
·
1 min read
·
Gabrielle Masson
